SCHEMBL6561697

SCHEMBL6561697

C=CCc1c(O)ccc2c1ccn2-c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.38
CYP19A1 P11511 1/20 0.35
SRD5A1 P18405 1/20 0.33
PLA2G2A P14555 1/20 0.32
CASR P41180 1/20 0.32
ALDH1A1 P00352 2/20 0.31
ALOX15 P16050 1/20 0.31
HTT P42858 1/20 0.31
ATM Q13315 1/20 0.31
XDH P47989 1/20 0.31
KCNH2 Q12809 4/20 0.31
GABRA1 P14867 2/20 0.30
GABRB2 P47870 2/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH2 P05091 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
AKR1B1 P15121 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561562 0.71 PLA2G2A (0.37) CYP19A1SRD5A1PLA2G2ACASRALDH1A1
SCHEMBL2002745 0.69 SRD5A1 (0.34) SRD5A1PLA2G2AALDH1A1XDHGABRA1
SCHEMBL6561182 0.68 ALDH1A1 (0.47) CYP19A1PLA2G2AALDH1A1HTTXDH
SCHEMBL6398012 0.68 SRD5A1 (0.49) SRD5A1ALDH1A1XDHGABRA1GABRB2
SCHEMBL323547 0.66 XDH (0.54) SRD5A1ALDH1A1HTTXDHGABRA1
Hydrogen Sulfide SCHEMBL6721312 0.64 XDH (0.52) SRD5A1ALDH1A1XDHGABRA1GABRB2
SCHEMBL7856928 0.64 SRD5A1 (0.40) SRD5A1PLA2G2ACASRALDH1A1KDM4E
SCHEMBL2454840 0.64 SRD5A1 (0.45) SRD5A1PLA2G2AALDH1A1XDHGABRA1
SCHEMBL10639712 0.62 CYP3A4 (0.46) SRD5A1PLA2G2AALDH1A1ALOX15HTT
SCHEMBL6981762 0.62 ALDH1A1 (0.50) BIRC5CYP19A1ALDH1A1ALOX15HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0904079-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2004-03-24 EP disclosed
EP-0904079-A4 1999-05-06 EP disclosed
EP-0904079-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-03-31 EP disclosed
US-5859051-A ACETYLPHENOL DERIVATIVES MERCK & CO., INC. (US) 1999-01-12 US disclosed
WO-1997027857-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed